Indian pharmaceutical Company, Austrak launches Nephrology and urology division

Hyderabad, June 22, 2022: Indian Pharmaceutical Company, Austrak private limited based in Hyderabad, Telangana, launched its new super specialty division to focus on around 73 valued products in Nephrology and urology. With a strong presence in the segment of ophthalmology for the last 12 years, Austrak is one of the leading innovation driven healthcare group, whose core businesses are pharmaceuticals and surgical. Austrak aims to supply products and services that significantly improve people's lives by helping to prevent, diagnose and treat disease.

Speaking on the occasion, Vittal – Chairman Austrak Pvt Ltd said that, Quality is the prime focus at Austrak. All our products are manufactured in W.H.O. / GMP standard manufacturing plants and all facilities meet CGMP standards. In line with our ambitious growth plans, we are launching our Nephrology and Urology division today. This division to focus on around 73 valued products in the segment. Our aim is to develop & market high quality specialty, therapeutic & medical products to cure critical illnesses like Chronic Kidney Disease (CKD) and Urology related ailments with their high prevalence, morbidity and mortality & ease sufferings.

He added that “We aspire to become one of the leading pharmaceutical companies that made advanced health care affordable and accessible for the masses in every corner of India.

Our aim is to develop & market high quality specialty, therapeutic & medical products to cure critical illnesses & ease sufferings. Large numbers of patients below the poverty line, low gross domestic product, and low monetary allocations for health care have led to suboptimal outcomes. Moreover, CKD, Urinary problems and other non-communicable diseases have often been ignored in the face of persistent challenges due to competition for resources of communicable diseases and high infant and maternal mortality.

The principal contribution of Austrak private limited to the society is to continue commuting substantial resources to long term strategy of discovering & getting innovative products that improve the quality of human life.

Our products and services make it possible for patients to receive prompt and effective treatment tailored to their individual requirements. By helping patients to avoid or shorten costly hospital stays, they help to reduce the overall cost of healthcare for individuals and society.”